Emirates Drug Establishment approves new indication for Foundayo to treat type 2 diabetes

The Emirates Drug Establishment has cleared Foundayo for use in managing type 2 diabetes. This expands treatment options for the condition across the UAE. The move may influence activity in the local pharmaceutical sector and related healthcare markets.
Read the full story at Zawya →
This is a short summary written by Entrepreneurs Of Dubai. The full article, its reporting and its images belong to Zawya.
